Novo Nordisk is facing “unprecedented” price pressures, “intensifying competition” and patents expiring.
Wegovy-maker Novo Nordisk warns price cuts ‘painful’ for firm as shares plunge
February 14, 2026
- It’s been a big — but rocky — week for AI models from China. Here’s what’s happened
- Gordon Ramsay denies Victoria Beckham got handsy with Brooklyn at his wedding
- From sisters to strangers: Jesy Nelson on painful Little Mix fallout
- iPhone 18 Pro may offer satellite-enabled 5G, thanks to Apple’s A20 chipset
Headlines
